nDatalyze Corp (NDATF) Fair Value & Analysis
Healthcare · US · Market cap $6.1M
Fair value as of: Jun 26, 2026
Analysis
nDatalyze Corp (NDATF) currently trades at $0.0800, while our model-based Fair Value estimate is $0.0240 — implying the stock looks roughly 70.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
nDatalyze Corp. provides technologically based solutions related to applying machine learning to a records database to predict probable mental health conditions. It offers Sigmund, a machine-learning-based online mental health application for the mental health system, such as misdiagnosis and mis prescription. The company was formerly known as MedXtractor Corp. and changed its name to nDatalyze Corp. in October 2021. nDatalyze Corp. was incorporated in 2018 and is headquartered in Calgary, Canada.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is nDatalyze Corp (NDATF) undervalued?
What is the fair value of NDATF?
What is the quality score of NDATF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.